Clinical Trial Update: Assess the Immunogenicity & Safety of 2 Doses of Oral Live Attenuated Human Rota(HRV)Vaccine in Healthy Infants in India [Phase 3]

View source ↗

Summary

Phase 3 trial assessing immunogenicity and safety of two doses of an oral live attenuated rotavirus vaccine in healthy Indian infants; the study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rotavirus Infection

Drugs mentioned

• Rotarix (Rotavirus vaccine (live attenuated))

Snippet

Sponsor: GlaxoSmithKline | Conditions: Infections, Rotavirus | Phase 3 | Status: COMPLETED